Safety and Immunogenicity of Neonatal Pneumococcal Conjugate Vaccination in Papua New Guinean Children: A Randomised Controlled Trial

BACKGROUND: Approximately 826,000 children, mostly young infants, die annually from invasive pneumococcal disease. A 6-10-14-week schedule of pneumococcal conjugate vaccine (PCV) is efficacious but neonatal PCV may provide earlier protection and better coverage. We conducted an open randomized contr...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: Pomat, William S., van den Biggelaar, Anita H. J., Phuanukoonnon, Suparat, Francis, Jacinta, Jacoby, Peter, Siba, Peter M., Alpers, Michael P., Reeder, John C., Holt, Patrick G., Richmond, Peter C., Lehmann, Deborah
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Public Library of Science 2013
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579820/
https://ncbi.nlm.nih.gov/pubmed/23451070
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0056698
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια